Quinlan Paul T has filed 4 insider transactions across 1 company since January 2025.
Most recent transaction: a sale of 733 shares of Oruka Therapeutics, Inc. ($ORKA) on March 16, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Oruka Therapeutics, Inc. | $ORKA | Quinlan Paul T | General Counsel | S | Common Stock | 733 | $41.30 | 31,767.0000 | 42,095,951 | 2.26% | 0.00% |
| Jan. 23, 2026 | Oruka Therapeutics, Inc. | $ORKA | Quinlan Paul T | General Counsel | A | Common Stock | 32500 | $0.00 | 32,500.0000 | 42,095,951 | 9999.99% | 0.08% |
| Jan. 23, 2026 | Oruka Therapeutics, Inc. | $ORKA | Quinlan Paul T | General Counsel | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 42,095,951 | 9999.99% | 0.31% |
| Jan. 22, 2025 | Oruka Therapeutics, Inc. | $ORKA | Quinlan Paul T | General Counsel | A | Employee Stock Option (right to buy) | 162500 | $0.00 | 162,500.0000 | 16,789,362 | 9999.99% | 0.97% |